D Amp M Pharma Peru Sac

In 2025, DIGEMID is pushing for a fully digital Visibilidad de Precios system. D & M Pharma must adapt their ERP systems to integrate with government price-monitoring software or face fines.

appears to be a formally registered Peruvian closed corporation in the pharmaceutical sector. However, the name alone does not guarantee reliability, compliance with health regulations, or financial solvency. In Peru’s pharmaceutical market, strict regulatory oversight by DIGEMID and SUNAT is the norm—but not all companies adhere to it.

: Biosol LC and various topical treatments for hair and skin health. Mission and Philosophy d amp m pharma peru sac

: Professional updates and corporate news are frequently posted on the D&M Pharma Perú LinkedIn page. D & M Pharma Peru S.A.C. Company Profile - EMIS

Access the D&M Pharma Peru Adverse Event Reporting Form to register safety documentation. Supply Chain and Market Role In 2025, DIGEMID is pushing for a fully

To bridge the gap between global pharmaceutical innovation and local healthcare needs, ensuring that medical facilities, pharmacies, and patients across Peru receive authentic, high-quality products in a timely and ethical manner.

: Av. Pablo Carriquiry 660, Piso 3, Urb. Corpac, San Isidro, Lima, Peru. Team Size : Approximately 32 employees as of 2024. Key Leadership : Jorge Rojas serves as the General Manager. However, the name alone does not guarantee reliability,

: Inhaler therapies such as Salbutral (salbutamol) intended to support acute and chronic bronchospasm management. Corporate Structure and Quality Management